FDA 483 - Hangzhou Facecare Cosmetics Co., Ltd. - June 19, 2017

An FDA inspection of Hangzhou Facecare Cosmetics Co. Ltd in Hangzhou, China, revealed 12 significant deficiencies in their drug manufacturing operations. The firm failed to conduct essential testing for active ingredients, establish expiration dates, perform stability studies, or validate critical processes and equipment. These widespread issues indicate a severe lack of adherence to Good Manufacturing Practices.